Current uses of aromatase inhibitors in gynecology

Middle East Fertility Society Journal

Volumn 7, Issue 3, 2002, Pages 173-179

  Elnashar, Aboubakr M ^a  

^a NONE   (Egypt)

Author keywords

Aromatase inhibitor; Breast cancer; Endometriosis; Ovulation induction

Indexed keywords

AMINOGLUTETHIMIDE; ANASTROZOLE; ANDROGEN; AROMATASE INHIBITOR; CLOMIFENE CITRATE; ESTROGEN; FOLLITROPIN; GESTAGEN; GOSERELIN; LETROZOLE; MEGESTROL; TAMOXIFEN;

BACKACHE; BONE PAIN; BREAST CANCER; DRUG POTENCY; DRUG SPECIFICITY; DRUG TOLERABILITY; EDEMA; ENDOMETRIOSIS; ESTROGEN SYNTHESIS; FATIGUE; GENE AMPLIFICATION; GONADOTROPIN RELEASE; GYNECOLOGY; HEADACHE; HOT FLUSH; HUMAN; INFERTILITY; MENSTRUAL CYCLE; NAUSEA; OVARY FOLLICLE; OVULATION INDUCTION; RASH; REVIEW; SIDE EFFECT;

EID: 0036977879     PISSN: 11105690     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. Higa GM. Altering the estrogenic milieu of breast cancer with a focus on the new aromatase inhibitors. Pharmacotherapy 2000; 20:280-91.
2. Brodie A, Inkster S. Aromatase in the human testis. J Steroid Biochem Mol Biol 1993:44:549-55.
3. Bulun SE, Simpson ER. Regulation of aromatase expression in human tissues. Breast Cancer Res Treat 1994;30:19-29.
4. Speroff L, Glass RH, Kase NG. Clinical gynecologic endocrinology and infertility. Baltimore: Lippincott, Williams and Wilkins, 6th Ed, 1999: 31-105.
5. Kaufmann M, Bajetta E, Dirix LY, et al. Exemestane is superior to megestrol acetate after tamoxifen failure in postmenopausal women with advanced breast cancer: results of a phase III randomized double-blind trial. J Clin Oncol 2000;18:1399-411.
6. Toi M, Bando H, Saji S. Aromatase and aromatase inhibitors. Breast Cancer 2001;8:329-32.
7. Dombemowsky P, Smith I, Falkson G, et al. Letrozole, a new oral aromatase inhibitor for advanced breast cancer; double-blind randomized trial showing a dose effect and improved efficacy and tolerability compared with megestrol acetate. J Clin Oncol 1998;6:453-61.
8. Lamb HM, Adkins JC. Letrozole, a review of its use in postmenopausal women with advanced breast cancer. Drugs 1998;56:1125-40.
9. Dowsett M, Lonning P. Anastrozole: a new generation in aromatase inhibition. Oncology 1997;54:11-4.
10. Dowsett M, Jones A, Johnston S, Jacobs S, Trunet P, Smith I. In vivo measurement of aromatase inhibition by Letrozole in postmenopausal patients with breast cancer. Clin Cancer Res 1995;1:1511-5.
11. Nuijten M, Meester L, Waibel F, Wait S. Cost effectiveness of Letrozole in the treatment of advanced breast cancer in postmenopausal women in the UK. Pharmacoeconomics 1999;16:379-97.
12. Mouridsen H, Gershanvich M, Sun Y, et al. Superior efficacy of Letrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer. Clin Oncol 2001;19:2596-606.
13. Howell A. Preliminary experience with pure antiestrogens. Clin Cancer Res 2001;7:4369s-75s.
14. Buzdar A, Jonat W, Howell A et al. Anastrozole, a potent and selective aromatase inhibitor, versus megestrol acetate in post menopausal women with advanced breast cancer. J Clin Oncol 1996;14:2000-11.
15. Berstein LM, Masksimov SI, Gershfel ED, et al. Neoadjuvant use of aromatase inhibitor Letrozole in uterine cancer: endocrine and clinical effects. Vopr Onkol 2001;47:571-4. English abstract
16. Maluf FC, Sabbatini P, Schwartz L, Xia J, Aghajanian C. Endometrial stromal sarcoma: objective response to Letrozole. Gynecol Oncol 2001;82:384-8
17. Bulun S, Zeitoun K, Takayama K, et al. Estrogen production in endometriosis and use of aromatase inhibitors to treat endometriosis. Endocr Relat Cancer 1999; 6: 293-301.
18. Bulun S, Yang S, Fang Z, Gurates B, et al. Role of aromatase in endometrial disease. J Steroid Biochem Mol Biol 2001;79:19-25.
19. Fang Z, Yang S, Tamura M, Gurates B, Bulun S. Treatment with aromatase inhibitor Letrozole significantly reduced the size of ectopic uterine implants. Fertil Steril 2001;76:46S
20. Muderris II. Aromatase inhibitors in the treatment of endometriosis with severe pain. Abstracts of the 18th Annul Meeting of the ESHRE, Vienna, Austria 2002. Hum Rep 2002;17:182.
21. th Annul Meeting of the ESHRE, Bologna, Italy 2000. Hum Rep 2000;15:38.
22. Vercillini P, DeGiorgi O, Pesole A et al. Endometriosis: drugs and adjuvant therapy. In: Templeton A, Cooke I, O Brien PMS.(eds) Evidence-based Fertility Treatment. London, RCOG Press, 1998:225-45.
23. Krasnopolskaya K, Kaluina A. Application of aromatase inhibitors (Anastrozole) in an IVF programme for the treatment of infertility associated with severe endometriosis. Abstracts of the 18th Annul Meeting of the ESHRE, Vienna, Austria 2002. Hum Rep 2002;17:149.
24. Mitwally FM and Casper RF. Aromatase inhibition: a novel method of ovulation induction in women with polycystic ovarian disease. Reprod Technol 2000,10:244-7.
25. Mitwally FM and Casper RF. Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate. Fertil Steril 2001; 75: 305-9.
26. Vendola KA, Zhou J, Adesanya OO, Weil SJ, Bondy CA. Androgens stimulate early stages of follicular growth in the primate ovary. J Clin Invest 1998; 101: 2622-9.
27. Mitwally MF, Casper RF. The aromatase inhibitor, Letrozole: a promising alternative for clomiphene citrate for induction of ovulation. Fertil Steril 2000; 74: S35-S7.
28. Metawie MH. Comparative study of aromatase inhibitor, Letrozole, with clomiphene citrate for induction of ovulation. Mid East Fertil Soc J 2001;6:11S.
29. Al-Omari W, Al-Hadithi N, Izat B, Sulaiman W. The effect of an aromatase inhibitor on ovulation induction and endometrial receptivity in clomiphene resistant women with polycystic ovary syndrome. Mid East Fertil Soc J 2001;6:21S-22S.
30. Elnashar A, Fouad H, Dosoky M, Saied N. The use of Letrozole for induction of ovulation in cases of CC failure. M.Sc. thesis(Obste and Gynecol), Benha Faculty of Medicine. Zagazig University, Egypt;2002:52-6.
31. Al-Omari W, Al-Hadithi N, Izat B, Sulaiman W. Comparison of two aromatase inhibitors in CC resistant PCOS. Abstracts of the 18th Annul Meeting of the ESHRE, Vienna, Austria 2002. Hum Rep 2002;17:84.
32. Sammour A, Biljan MM, Tan SL, Tulandi T. Prospective randomized trial comparing the effects of Letrozole and clomiphene citrate on follicular development, endometrial thickness and pregnancy rate in patients undergoing superovulation prior to intrauterine insemination. Fertil Steril 2001; 76:S110-S2.
33. El Helw B, El Sadek M, Matar H, Fouad S, El Nomrosy K, Abbas H. Single dose Letrozole versus CC for superovulation prior to intrauterine insemination: a prospective randomized study. Abstracts of the 18th Annul Meeting of the ESHRE, Vienna, Austria 2002. Hum Rep 2002;17:73.
34. Mitwally MF, Casper RF. Aromatase inhibition improves ovarian response to FSH: A potential option for low responders during ovarian stimulation. Fertil Steril 2002;77:776-80.
35. Tsirigotis M, Prapas G, Pistofidis G, Tika M, Pelekanos M. Experience with the use of Letrozole in patients with a history of poor ovarian response in previous assisted reproductive cycles. Abstracts of the 18th Annul Meeting of the ESHRE, Vienna, Austria 2002. Hum Rep 2002;17:34.
36. Femara (Letrozole) package insert. Novartis Pharmaceuticals Corporation, East Hanover, NJ 1999.